[MYGN] YoY Quarter Result on 30-Sep-2012 [#Q3]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
09-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- 3.41%
YoY- 20.07%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Revenue 183,500 168,837 202,467 133,437 110,452 91,858 85,122 13.65%
PBT 43,500 25,877 83,827 49,822 41,805 36,178 31,410 5.57%
Tax 16,900 9,895 28,362 19,686 16,706 13,640 968 61.03%
NP 26,600 15,982 55,465 30,136 25,099 22,538 30,442 -2.22%
Tax Rate -38.85% -38.24% -33.83% -39.51% -39.96% -37.70% -3.08% -
Total Cost 156,900 152,855 147,002 103,301 85,353 69,320 54,680 19.19%
Ratio Analysis
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
NP Margin 14.50 9.47 27.39 22.58 22.72 24.54 35.76 -13.96%
Per Share
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
EPS 0.39 0.22 0.70 0.37 0.29 0.24 0.32 3.35%
EPS Diluted 0.37 0.21 0.68 0.36 0.29 0.24 0.31 2.99%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.